Simplex Trading’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$115 Buy
25,400
+2,900
+13% +$298K ﹤0.01% 8869
2025
Q4
$2.29M Sell
22,500
-42,000
-65% -$3.37M ﹤0.01% 1873
2025
Q3
$3.53M Buy
64,500
+5,400
+9% +$270K ﹤0.01% 1782
2025
Q2
$3.14M Buy
59,100
+24,700
+72% +$1.25M ﹤0.01% 1718
2025
Q1
$1.49M Sell
34,400
-52,700
-61% -$2.67M ﹤0.01% 2325
2024
Q4
$4.89M Sell
87,100
-134,600
-61% -$8.38M ﹤0.01% 1493
2024
Q3
$15.1M Buy
221,700
+136,700
+161% +$7.71M 0.01% 789
2024
Q2
$3.59M Sell
85,000
-195,200
-70% -$10.7M ﹤0.01% 1674
2024
Q1
$19.4M Buy
280,200
+140,100
+100% +$8.86M 0.01% 714
2023
Q4
$10.4M Buy
140,100
+98,400
+236% +$6.45M 0.01% 1063
2023
Q3
$2.84M Sell
41,700
-56,400
-57% -$4.79M ﹤0.01% 1785
2023
Q2
$9.21M Buy
98,100
+59,100
+152% +$4.61M 0.01% 943
2023
Q1
$2.64M Sell
39,000
-94,100
-71% -$6.05M ﹤0.01% 1712
2022
Q4
$6.59M Buy
133,100
+74,600
+128% +$3.05M 0.01% 1071
2022
Q3
$1.9M Buy
58,500
+47,400
+427% +$1.95M ﹤0.01% 2002
2022
Q2
$437K Sell
11,100
-39,400
-78% -$2.11M ﹤0.01% 3602
2022
Q1
$3.53M Sell
50,500
-11,900
-19% -$870K ﹤0.01% 1551
2021
Q4
$4.86M Buy
62,400
+12,700
+26% +$1.12M ﹤0.01% 1225
2021
Q3
$6.17M Hold
49,700
0.01% 1032
2021
Q2
$6.18M Buy
49,700
+49,383
+15,578% +$5.89M 0.01% 1008
2021
Q1
$4.18M Buy
+317
New +$43.4K 0.01% 959
2020
Q4
Sell
-1,056
Closed -$10.8M 8537
2020
Q3
$10.8M Sell
1,056
-143
-12% -$12.3K 0.01% 489
2020
Q2
$10.4M Buy
1,199
+203
+20% +$16.2K 0.02% 511
2020
Q1
$5.78M Buy
+996
New +$80.9K 0.01% 628
2019
Q4
Sell
-1,178
Closed -$10.6M 7455
2019
Q3
$10.6M Buy
1,178
+86
+8% +$9.8K 0.03% 400
2019
Q2
$12.9M Buy
1,092
+567
+108% +$57.1K 0.04% 327
2019
Q1
$4.55M Sell
525
-556
-51% -$47.3K 0.01% 744
2018
Q4
$6.82M Sell
1,081
-637
-37% -$43.7K 0.02% 459
2018
Q3
$13.6M Buy
1,718
+1,210
+238% +$78.9K 0.04% 280
2018
Q2
$3.04M Sell
508
-268
-35% -$14.4K 0.01% 840
2018
Q1
$506K Buy
776
+159
+26% +$7.76K 0.02% 708
2017
Q4
$158K Buy
617
+10
+2% +$534 0.01% 1454
2017
Q3
$39K Buy
607
+1
+0.2% +$40 ﹤0.01% 2531
2017
Q2
$58K Buy
606
+179
+42% +$5.53K ﹤0.01% 2248
2017
Q1
$114K Sell
427
-469
-52% -$9.29K ﹤0.01% 1639
2016
Q4
$331K Buy
896
+179
+25% +$2.89K 0.02% 757
2016
Q3
$164K Sell
717
-720
-50% -$12.7K 0.01% 1167
2016
Q2
$202K Buy
1,437
+1,022
+246% +$7.7K 0.01% 986
2016
Q1
$268K Buy
415
+313
+307% +$2K 0.02% 710
2015
Q4
$108K Buy
102
+34
+50% +$316 0.01% 1286
2015
Q3
$85K Sell
68
-22
-24% -$505 0.01% 1537
2015
Q2
$43K Buy
90
+33
+58% +$829 ﹤0.01% 1800
2015
Q1
$54K Sell
57
-126
-69% -$3.2K 0.01% 1499
2014
Q4
$55K Buy
+183
New +$4.45K 0.01% 1317

Other funds holding EXAS

Simplex Trading's EXAS Position: Q1 2026 in Review

Simplex Trading sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 22,521 shares — an estimated $2.32M sold.

Simplex Trading first reported a position in EXAS in Q1 2016 and held it in 24 quarters. The position peaked at $8.14M in Q1 2024. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Simplex Trading reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 22,521 Exact Sciences shares in Q1 2026, an estimated $2.32M.
  • Simplex Trading first reported a position in Exact Sciences in Q1 2016 and held it in 24 quarters.
  • Simplex Trading's Exact Sciences position peaked at $8.14M in Q1 2024.
  • 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.